What Is Anovulatory Infertility?
Anovulatory infertility occurs when a woman does not ovulate regularly, preventing conception. It accounts for 25-30% of all cases of female infertility and is considered the most treatable cause, with high success rates with adequate ovulation induction.
Normal ovulation requires precise coordination of the hypothalamic-pituitary-ovarian axis. Any disruption of this axis — from the hypothalamus (stress, extreme weight), the pituitary (hyperprolactinemia), or the ovary (PCOS, ovarian insufficiency) — can result in anovulation.
Anovulation may manifest as amenorrhea (absence of menstruation), oligomenorrhea (long, irregular cycles), or, in some cases, apparently regular cycles without effective ovulation (eugonadotropic anovulation).
Treatable Cause
Anovulatory infertility is the most treatment-responsive cause, with ovulation rates of 60-90% with appropriate pharmacotherapy.
WHO Classification
Divided into 3 groups by level of dysfunction: hypothalamic (Group I), ovarian with PCOS (Group II), or ovarian insufficiency (Group III).
PCOS Is the Main Cause
Polycystic ovary syndrome accounts for 70-80% of chronic anovulation and anovulatory infertility cases.
Pathophysiology
Normal ovulation requires a precise sequence of events: GnRH pulses from the hypothalamus stimulate FSH and LH secretion by the pituitary; FSH promotes follicular development and estradiol production; the estradiol peak triggers the LH surge, which induces follicular rupture and oocyte release.
In WHO Group I anovulation (hypogonadotropic hypogonadism), there is GnRH deficiency, resulting in low FSH and LH levels. Causes include functional hypothalamic amenorrhea (stress, excessive weight loss, intense exercise), Kallmann syndrome, and hypothalamic lesions.
In WHO Group II anovulation (normogonadotropic), FSH and LH levels are normal, but there is dysfunction in follicular maturation — typically PCOS. In Group III (hypergonadotropic), there is ovarian failure with elevated FSH and depleted ovarian reserve, the most therapeutically challenging cause.
WHO CLASSIFICATION FOR ANOVULATION
| GROUP | FSH/LH | MAIN CAUSE | PROGNOSIS |
|---|---|---|---|
| Group I | Low | Hypothalamic amenorrhea, Kallmann | Excellent with gonadotropins |
| Group II | Normal | PCOS (70-80% of cases) | Very good with letrozole/clomiphene |
| Group III | Elevated | Premature ovarian insufficiency | Reserved (consider oocyte donation) |
Symptoms
The main sign of anovulation is menstrual irregularity — very long cycles (> 35 days), very short, or absent. However, some anovulatory cycles may appear regular, making identification difficult without proper investigation.
Signs of Anovulation
- 01
Irregular cycles
Oligomenorrhea (cycles > 35 days) or amenorrhea (absence > 3 months) are the most common indicators.
- 02
Absence of ovulatory symptoms
Lack of fertile cervical mucus, ovulatory pain (mittelschmerz), or rising basal body temperature in the second cycle phase.
- 03
Infertility
Inability to conceive after 12 months of unprotected intercourse (or 6 months if > 35 years).
- 04
Abnormal uterine bleeding
Irregular, prolonged, or excessive bleeding from lack of progestational opposition to the endometrium.
- 05
Signs of hyperandrogenism
If the cause is PCOS: hirsutism, acne, alopecia — indicating androgen excess.
- 06
Signs of hypoestrogenism
If the cause is hypothalamic or ovarian insufficiency: vaginal dryness, hot flashes, decreased libido.
Diagnosis
Diagnosing anovulation requires laboratory confirmation and identification of the underlying cause. Serum progesterone measured on day 21 of the cycle (or 7 days after expected ovulation) is the simplest test — values above 3 ng/mL confirm ovulation.
🏥Investigation of Anovulation
- 1.Luteal-phase serum progesterone (day 21-23): < 3 ng/mL confirms anovulation
- 2.Basal FSH and LH (day 3): classify the WHO group
- 3.Estradiol, prolactin, and TSH: rule out hyperprolactinemia and thyroid dysfunction
- 4.Total testosterone and DHEA-S: assess hyperandrogenism (PCOS, adrenal hyperplasia)
- 5.Pelvic ultrasound: evaluates ovarian and endometrial morphology
- 6.AMH (anti-Müllerian hormone): assesses ovarian reserve
DIAGNÓSTICO DIFERENCIAL
Differential Diagnosis
Polycystic Ovary Syndrome
Read more →- Oligomenorrhea or amenorrhea
- Clinical or biochemical hyperandrogenism
- Polycystic ovaries on ultrasound
Testes Diagnósticos
- Total testosterone
- DHEA-S
- Transvaginal ultrasound
- Rotterdam criteria
Regulates the hypothalamic-pituitary-ovarian axis and improves insulin sensitivity
Hyperprolactinemia
- Spontaneous galactorrhea
- Oligomenorrhea or amenorrhea
- Prolactin above 25 ng/mL
- Headache and visual changes — suspected macroprolactinoma
Testes Diagnósticos
- Serum prolactin
- Pituitary MRI if prolactin elevated
Early evidence of prolactin modulation; adjunctive to pharmacologic treatment
Premature Ovarian Insufficiency
- Amenorrhea or oligomenorrhea before age 40
- FSH above 25 IU/L on two measurements
- Symptoms of hypoestrogenism
- Early osteoporosis
- Increased cardiovascular risk
Testes Diagnósticos
- FSH and estradiol
- AMH
- Ultrasound with antral follicle count
Limited role; may help manage hypoestrogenism symptoms
Asherman Syndrome
- History of curettage or uterine surgery
- Amenorrhea or hypomenorrhea
- Uterine cavity with synechiae
Testes Diagnósticos
- Hysteroscopy
- Hysterosalpingography
No specific evidence; may complement general fertility care
Hypothyroidism
Read more →- Fatigue, weight gain, constipation
- Irregular menstrual cycles
- Elevated TSH
Testes Diagnósticos
- TSH and free T4
Modulates the autonomic nervous system; does not replace thyroid hormone replacement
Polycystic Ovary Syndrome
PCOS is the most common cause of chronic anovulation, accounting for 75-85% of anovulatory infertility cases. Diagnosis follows the Rotterdam criteria (2003), which require at least 2 of 3 criteria: oligo-ovulation/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovaries on ultrasound.
Early studies investigate acupuncture effects in PCOS on HPO axis modulation, LH/androgen levels, and insulin sensitivity — heterogeneous findings that require confirmation in multicenter trials. For women with PCOS seeking pregnancy, acupuncture may be considered a complement to pharmacologic ovulation induction (letrozole or clomiphene citrate), never a substitute.
Hyperprolactinemia
Hyperprolactinemia causes anovulation by inhibiting hypothalamic GnRH pulsatility. The classic clinical picture includes galactorrhea, amenorrhea, and infertility. The most common cause is prolactinoma (a benign pituitary tumor), followed by hypothyroidism, stress, and medications (haloperidol, metoclopramide).
Prolactin measurement should be part of the basic workup for any anovulation. Prolactin above 200 ng/mL suggests macroprolactinoma and requires pituitary MRI. Cabergoline treatment normalizes prolactin and restores ovulation in 80-90% of cases.
Premature Ovarian Insufficiency
Premature ovarian insufficiency (POI) is defined as ovarian failure before age 40, with elevated FSH and low estradiol. It differs from PCOS by presenting decreased ovarian reserve (low AMH, few antral follicles) rather than follicle excess. The prognosis for spontaneous pregnancy is reserved, with only 5-10% spontaneous pregnancy.
Women with POI should be referred for specialized assisted reproduction evaluation. Hormone replacement is indicated to prevent osteoporosis and cardiovascular disease. Acupuncture may help manage hypoestrogenism symptoms but does not change the reproductive prognosis.
Treatment
Treatment depends on the cause of anovulation (WHO group) and reproductive goals. The immediate goal is restoring ovulation; the final goal is pregnancy. The approach is highly individualized.
Correction of Reversible Factors
Weight normalization (gain in hypothalamic amenorrhea, 5-10% loss in PCOS with overweight), stress reduction, and treatment of hyperprolactinemia (cabergoline) or thyroid dysfunction.
Letrozole (First-Line for PCOS)
Aromatase inhibitor, 2.5-7.5 mg/day for 5 days (cycle days 3-7). Superior to clomiphene in ovulation rates and live births in PCOS. Ovulation rate: 60-80% per cycle.
Clomiphene Citrate (Alternative)
Selective estrogen receptor modulator, 50-150 mg/day for 5 days. Ovulation rate: 60-80%. Cumulative pregnancy rate: 50-60% in 6 ovulatory cycles.
Gonadotropins and IVF
For refractory cases or Group I. Low-dose gonadotropins with follicular monitoring. IVF when other options fail or associated factors are present.
Acupuncture as Treatment
Acupuncture is being investigated as complementary therapy in anovulatory infertility, focusing on hypothalamic-pituitary-ovarian axis modulation and improved ovulatory function. Experimental studies demonstrate electroacupuncture effects on GnRH pulsatility and ovarian sympathetic activity.
Clinical evidence is more consistent for regulating the menstrual cycle and reducing stress than for directly increasing the pregnancy rate. In functional hypothalamic amenorrhea (Group I), stress modulation by acupuncture has physiologic rationale, since stress is one of the central mechanisms of hypothalamic dysfunction.
Acupuncture may be considered adjunctive to pharmacologic ovulation induction, not a substitute. Its role is complementary, contributing to stress management, autonomic regulation, and well-being during infertility treatment.
Prognosis
The prognosis of anovulatory infertility is generally favorable for WHO Groups I and II. With adequate treatment, most women with PCOS can ovulate and conceive. The cumulative pregnancy rate at 6 ovulatory cycles with letrozole or clomiphene is 50-60%.
Group III (ovarian insufficiency) has a more reserved prognosis. Oocyte donation is often the option with the best success rates, although spontaneous pregnancies occur in 5-10% of premature ovarian insufficiency cases.
Factors influencing prognosis include age, duration of infertility, presence of other factors (tubal, male), body mass index, and response to the first treatment cycle.
Myths and Facts
Myth vs. Fact
If I menstruate, I am ovulating
Menstrual bleeding does not guarantee ovulation. Anovulatory cycles can produce estrogen-withdrawal bleeding without releasing an egg.
Anovulatory infertility always requires IVF
Most cases respond to oral ovulation induction (letrozole or clomiphene), with no need for IVF. IVF is reserved for refractory cases or those with associated factors.
Yam tea induces ovulation
No scientific evidence shows that yam tea or any home herbal remedy reliably induces ovulation. Ovulation induction requires specific medication with monitoring.
Stress is the only cause of anovulation
Stress can cause hypothalamic amenorrhea (Group I), but the most common cause of anovulation is PCOS (Group II), which has an endocrine and genetic basis independent of stress.
When to Seek Help
Women with irregular cycles who wish to become pregnant should seek gynecologic evaluation without waiting the traditional 12 months, since anovulation is already clinically evident.
Frequently Asked Questions
Anovulatory infertility is the inability to conceive due to absent or irregular ovulation. It is the most common and most treatable cause of female infertility, accounting for 25-30% of cases. The most frequent causes are PCOS, hyperprolactinemia, hypothyroidism, and premature ovarian insufficiency.
Investigated mechanisms include potential modulation of the hypothalamic-pituitary-ovarian axis, GnRH pulsatility, and ovarian sympathetic activity — still under investigation. Early studies suggest effects on androgen levels in PCOS and on oxidative stress, with heterogeneous findings. The most consistently documented contribution is reducing stress associated with infertility treatment.
Not in couples with a medical indication for pharmacologic induction. Acupuncture may be complementary — improving response to clomiphene citrate or gonadotropins — or useful as an initial approach in young couples with mild anovulation and no urgency for results. The reproductive medicine specialist should make this decision.
Studies suggest HPO axis regulation benefits appear after 3 to 4 treatment cycles. The usual protocol involves 2 to 3 weekly sessions during the follicular and periovulatory phases. Response evaluation should include ultrasound monitoring of follicular development.
Yes. PCOS accounts for 75-85% of anovulatory infertility cases. Diagnosis follows the Rotterdam criteria, and treatment includes lifestyle changes, metformin (when insulin resistance is present), and first-line ovulation induction with clomiphene citrate or letrozole.
Yes. Hypothyroidism alters TRH levels, which stimulates prolactin secretion, causing functional hyperprolactinemia and anovulation. Hypothyroidism also directly alters ovarian function. TSH screening is mandatory in infertility workup — many women normalize their cycles after thyroid treatment adjustment.
Evidence is emerging, especially for PCOS. Swedish and Chinese studies suggest regular acupuncture may contribute to ovulatory frequency in women with PCOS. Evidence quality is limited to moderate, with methodologic heterogeneity — notably, the large randomized trial published in JAMA (Wu et al., 2017) in women with PCOS did not demonstrate acupuncture benefit on live birth rate compared with clomiphene. No data support equivalence to ovulation induction pharmacotherapy (letrozole, clomiphene). Acupuncture is considered a complement to conventional treatment, never a substitute.
Yes. Chronic stress activates the HPA axis, releasing cortisol that suppresses the hypothalamic reproductive axis. Functional hypothalamic amenorrhea — common in elite athletes, women with severe caloric restriction, and professionals under extreme stress — is a form of anovulation reversible with stress reduction.
Basic workup includes: cycle day 3 hormonal profile (FSH, LH, estradiol, prolactin, TSH), testosterone and DHEA-S measurement, transvaginal ultrasound with antral follicle count, AMH, and luteal-phase progesterone (to confirm ovulation). Partner semen analysis should be performed simultaneously.
The starting point is a gynecologist, preferably with experience in human reproduction. For couples who do not conceive after basic workup, referral to a reproductive medicine specialist is recommended. The acupuncture physician can integrate care as a complement to conventional treatment.
Related Reading
Deepen your knowledge with related articles